| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0624908c7150e45bdd907be4f162057e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ba3b8b37bfb72768c7601726154a79 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate |
2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8bb641aea2d1a364e7de81411b928ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b4a5f7fcbb97fc6b2e59ac231e62da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1bbe1c3e4452084a3718602d7f39806 |
| publicationDate |
2022-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220155553-A |
| titleOfInvention |
Composition and method for treating LCA10 using RNA-guided Nuclease |
| abstract |
The present invention relates to the treatment of LCA10 disease using the CRISPR/Cas12f1 (Cas14a1) system. More specifically, the present invention relates to a composition comprising the CRISPR/Cas12f1 (Cas14a1) system for the treatment of LCA10 disease and a treatment method using the same. In addition, the present invention relates to a composition comprising a CRISPR/Cas12f1 (Cas14a1) system for artificially manipulating the CEP290 gene and a method of manipulating the CEP290 gene using the same. |
| priorityDate |
2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |